A detailed history of Watts Gwilliam & Co., LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Watts Gwilliam & Co., LLC holds 8,573 shares of MRK stock, worth $827,637. This represents 0.2% of its overall portfolio holdings.

Number of Shares
8,573
Previous 6,042 41.89%
Holding current value
$827,637
Previous $777 Million 19.68%
% of portfolio
0.2%
Previous 0.24%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$111.15 - $128.97 $281,320 - $326,423
2,531 Added 41.89%
8,573 $930 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $684,196 - $797,241
6,042 New
6,042 $777 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $245B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Watts Gwilliam & Co., LLC Portfolio

Follow Watts Gwilliam & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Watts Gwilliam & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Watts Gwilliam & Co., LLC with notifications on news.